The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.70
Bid: 50.30
Ask: 50.50
Change: 1.00 (2.01%)
Spread: 0.20 (0.398%)
Open: 49.50
High: 51.00
Low: 49.50
Prev. Close: 49.70
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

28 Jan 2022 17:02

RNS Number : 0445A
IP Group PLC
28 January 2022
 

IP GROUP plc (the "Company")

 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 8 October 2021 (the Buyback Programme).

Date of purchase:

28-Jan-22

Number of ordinary shares purchased:

500,745

Highest price paid per ordinary share (GBp):

 95.80

Lowest price paid per ordinary share (GBp):

 93.00

Volume weighted average price paid per ordinary share (GBp):

94.4331

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 29,708,621 of its ordinary shares in treasury and has 1,063,033,287 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,033,324,666, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group confirms that the £35 million Buyback Programme announced on 8 October 2021 has now been completed.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Numis Securities Limited on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

28 January 2022

Number of ordinary shares purchased:

500,745

Volume weighted average price (pence):

94.4331

Individual transactions:

 

Number of sharespurchased

Transaction price(per share)

Time of transaction

Trading venue

159

95.70

 08:09:22

LSE

247

95.70

 08:09:22

LSE

1684

95.80

 08:09:22

LSE

7459

95.00

 08:10:11

LSE

2450

95.00

 08:10:11

LSE

526

95.00

 08:10:11

LSE

8622

94.30

 08:22:10

LSE

8615

95.50

 08:55:40

LSE

8369

95.20

 09:17:40

LSE

470

95.10

 09:41:51

LSE

200000

95.00

 09:42:01

LSE

10371

94.90

 09:43:36

LSE

8277

94.40

 10:09:38

LSE

505

94.40

 10:09:38

LSE

1604

94.40

 10:09:38

LSE

97

94.50

 10:22:30

LSE

568

94.40

 10:29:33

LSE

281

94.40

 10:29:33

LSE

773

94.40

 10:29:55

LSE

7259

94.40

 10:29:55

LSE

1125

94.40

 10:29:55

LSE

102

94.90

 11:13:21

LSE

3000

94.90

 11:15:39

LSE

5495

94.70

 11:23:42

LSE

3595

94.70

 11:23:42

LSE

9786

93.90

 12:22:20

LSE

9352

93.70

 13:22:02

LSE

886

93.70

 13:22:02

LSE

943

93.60

 14:15:02

LSE

8676

93.60

 14:15:02

LSE

9677

93.40

 14:45:19

LSE

8498

93.00

 15:01:21

LSE

352

93.00

 15:01:21

LSE

83

93.30

 15:15:48

LSE

9103

93.50

 15:27:26

LSE

1132

93.30

 15:35:41

LSE

3

93.40

 15:37:04

LSE

4

93.50

 15:37:13

LSE

4428

93.50

 15:37:40

LSE

5250

93.50

 15:37:40

LSE

7500

93.60

 15:41:18

LSE

1911

93.60

 15:41:18

LSE

6724

93.50

 15:41:46

LSE

1800

93.50

 15:41:46

LSE

8610

93.50

 15:42:26

LSE

496

93.40

 15:46:22

LSE

1594

93.40

 15:46:22

LSE

22

93.40

 15:48:03

LSE

2971

93.50

 15:48:17

LSE

193

93.50

 15:48:17

LSE

4979

93.50

 15:48:17

LSE

2500

93.50

 15:48:17

LSE

2500

93.50

 15:48:17

LSE

8183

93.50

 15:48:17

LSE

296

93.50

 15:48:17

LSE

1292

93.50

 15:48:17

LSE

307

93.50

 15:48:17

LSE

1639

93.80

 15:56:07

LSE

4884

93.80

 15:56:07

LSE

2664

93.80

 15:56:07

LSE

6512

93.80

 15:57:41

LSE

3256

93.80

 15:57:41

LSE

3

93.90

 16:00:02

LSE

2148

93.90

 16:02:10

LSE

5000

93.90

 16:02:10

LSE

3251

93.90

 16:02:10

LSE

7672

93.90

 16:02:10

LSE

1739

93.90

 16:02:10

LSE

236

93.90

 16:02:34

LSE

140

93.90

 16:02:34

LSE

1557

93.90

 16:02:34

LSE

12440

94.10

 16:05:05

LSE

138

94.10

 16:05:05

LSE

95

94.10

 16:05:05

LSE

3

94.10

 16:05:06

LSE

7801

94.10

 16:05:39

LSE

2071

94.10

 16:05:39

LSE

411

94.10

 16:05:39

LSE

1233

94.10

 16:05:39

LSE

2999

94.10

 16:05:39

LSE

1496

94.10

 16:05:39

LSE

3000

94.10

 16:05:39

LSE

10270

94.40

 16:11:37

LSE

5551

94.40

 16:15:17

LSE

10087

94.40

 16:15:17

LSE

745

94.50

 16:23:11

LSE

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGZMNRGGZZM
Date   Source Headline
17th Jun 20217:00 amRNSPortfolio company Apollo Therapeutics raises $145m
15th Jun 20218:00 amRNSFurther re Scrip Dividend
9th Jun 202111:29 amRNSResult of AGM
9th Jun 20217:00 amRNSAGM Statement
7th Jun 20217:00 amRNSPortfolio co Iksuda completes $42m financing round
28th May 20213:36 pmRNSDirector/PDMR Shareholding
28th May 202110:00 amRNSJoint venture with China Everbright to launch fund
27th May 20217:00 amRNSPortfolio co Pulmocide completes $92m Series C
26th May 20212:44 pmRNSUpdate on AGM
20th May 202110:01 amRNSScrip Dividend Reference Price
17th May 202112:44 pmRNSAdditional fair value gain of £20m
12th May 202112:08 pmRNSHolding(s) in Company
10th May 202111:15 amRNSInvestor webinars
6th May 20216:13 pmRNSNotice of AGM, Annual Report, Scrip Dividend
6th May 20215:55 pmRNSLTIP & DBSP awards; Director/PDMR shareholding
5th May 20217:00 amRNSPortfolio company Kuur acquired by Athenex
5th May 20217:00 amRNSPortfolio company Inivata acquired by NeoGenomics
4th May 20217:00 amRNSPortfolio company Oxford Nanopore raises £195m
7th Apr 202111:27 amRNSDirector/PDMR Shareholding
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20217:05 amRNSOxford Nanopore announces preparing for IPO in H2
26th Mar 202112:26 pmRNSEMA positive opinion for Diurnal's Chronocort
10th Mar 20217:00 amRNSAnnual Results
4th Mar 20216:07 pmRNSHolding(s) in Company
2nd Mar 202112:03 pmRNSHolding(s) in Company
24th Feb 202110:33 amRNSNotice of Results
18th Feb 20214:31 pmRNSHolding(s) in Company
18th Feb 20218:00 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSPortfolio company ApcinteX acquired by Centessa
10th Feb 20217:00 amRNSIP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 20213:52 pmRNSHolding(s) in Company
2nd Feb 20215:15 pmRNSHolding(s) in Company
11th Jan 20215:29 pmRNSHolding(s) in Company
6th Jan 20214:57 pmRNSPortfolio co Hinge Health completes $300m round
6th Jan 202111:34 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSPortfolio co Oxbotica completes £36m funding round
4th Dec 202011:41 amRNSHolding(s) in Company
3rd Dec 20208:01 amRNSArtios and Merck in global strategic collaboration
25th Nov 20207:00 amRNSDirector Declaration
23rd Nov 20205:05 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSInvestor webinar
13th Oct 20207:00 amRNSOxford Nanopore funding round and contract win
9th Oct 20209:46 amRNSOxford Nanopore's LamPORE test gains CE-IVD mark
7th Oct 20207:00 amRNSEnterprise Therapeutics' program acquired by Roche
23rd Sep 20201:40 pmRNSHolding(s) in Company
15th Sep 202012:07 pmRNSSecond Price Monitoring Extn
15th Sep 202012:02 pmRNSPrice Monitoring Extension
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20205:18 pmRNSForm 8.3 - Modern Water plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.